Sosei Heptares Announces that Ultibro® Breezhaler® and Seebri® Breezhaler® Launched in China for the Treatment of COPD

By In The News
March 21, 2019 in The Headlines

Recommended Posts

In The News

Posted March 21, 2019

- Share

Posted March 21, 2019

TOKYO and LONDON, March 21, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) confirms that Ultibro® Breezhaler® and Seebri® Breezhaler® have been launched by Novartis in China for the treatment of chronic obstructive pulmonary disease (COPD). The Company, together...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220022
2. Jaydee
  16843
3. Kip Powick
  12231
4. deicer
  12211
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.3k
- Total Posts
  
  559.1k

Sign In

Sosei Heptares Announces that Ultibro® Breezhaler® and Seebri® Breezhaler® Launched in China for the Treatment of COPD

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support